Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Yacoub, Abdulraheem; Mascarenhas, John; Kosiorek, Heidi; T. Prchal, Josef; Berenzon, Dmitry; R. Baer, Maria; Ritchie, Ellen; T. Silver, Richard; Kessler, Craig; Winton, Elliott; Chiara Finazzi, Maria; Rambaldi, Alessandro; M. Vannucchi, Alessandro; Leibowitz, David; Rondelli, Damiano; O. Arcasoy, Murat; Catchatourian, Rosalind; Vadakara, Joseph; Rosti, Vittorio; Hexner, Elizabeth; Kremyanskaya, Marina; Sandy, Lonette; Tripodi, Joseph; Najfeld, Vesna; Farnoud, Noushin; Papaemmanuil, Elli; Salama, Mohamed; Singer-Weinberg, Rona; Rampal, Raajit; D. Goldberg, Judith; Barbui, Tiziano; Mesa, Ruben; C. Dueck, Amylou; Hoffman, Ronald

doi:10.1182/blood.2019000428

Public

Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea

Shared by NobleBlocks on Sep 12, 2019 • 12:00 AM UTC

Authors:

Abdulraheem Yacoub

John Mascarenhas

Heidi Kosiorek

Abstract

Yacoub et al report excellent responses to pegylated interferon alfa-2a in patients with hydroxyurea-resistant/intolerant polycythemia vera or essential thrombocythemia.

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!